Daniel Thomson

4.4k citations

17 papers · 3.0k indexed · 1 hit paper · h-index 11

Impact in

Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Molecular Biology top 2%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- RNA Interference and Gene Delivery
- Extracellular vesicles in disease

Papers in ⓘ

Cancer Research 9
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 3
Hematology 6
- Chronic Myeloid Leukemia Treatments 6

Co-authors: Marcel E. Dinger (4 shared papers)Gregory J. Goodall (5 shared papers)Cameron P. Bracken (5 shared papers)Nenad Bartoniček (1 shared paper)Jesper L.V. Mååg (1 shared paper)Michael B. Clark (1 shared paper)Bethany Signal (1 shared paper)Brian Gloss (1 shared paper)
Journals: Nucleic Acids Research (4 papers)Blood (3 papers)Leukemia (2 papers)The EMBO Journal (1 paper)Psycho-Oncology (1 paper)
Partner nations: Australia Switzerland United States

In The Last Decade

Daniel Thomson

17 papers receiving 3.0k citations

Hit Papers

align trajectories log scale

Endogenous microRNA sponges: evidence and controversy 2016 · 1.6k citations

Peers

Countries citing papers authored by Daniel Thomson

Since Specialization

Citations

This map shows the geographic impact of Daniel Thomson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Thomson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Thomson more than expected).

Fields of papers citing papers by Daniel Thomson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Thomson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Thomson. The network helps show where Daniel Thomson may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Thomson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Thomson Line = papers co-authored together Daniel Thomson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Endogenous microRNA sponges: evidence and controversy Nature Reviews Genetics ·Daniel Thomson, Marcel E. Dinger Hit paper breakdown →	2016	1620
2	Experimental strategies for microRNA target identification Nucleic Acids Research ·Daniel Thomson, Cameron P. Bracken, Gregory J. Goodall	2011	442
3	lncRNAdb v2.0: expanding the reference database for functional long noncoding RNAs Nucleic Acids Research ·Xiu Cheng Quek, Daniel Thomson, Jesper L.V. Mååg, Nenad Bartoniček, Bethany Signal, Michael B. Clark, Brian Gloss, Marcel E. Dinger	2014	420
4	miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion European Journal of Cancer ·Adam Fowler, Daniel Thomson, Keith M. Giles, Sanaz Maleki, Ellein Mreich, Helen Wheeler, Peter J. Leedman, Michael T. Biggs, Raymond Cook, Nicholas Little, Bruce Robinson, Kerrie L. McDonald	2011	116
5	Genome‐wide identification of miR‐200 targets reveals a regulatory network controlling cell invasion The EMBO Journal ·Cameron P. Bracken, Xiaochun Li, Josephine A. Wright, David Lawrence, Katherine A. Pillman, Marika Salmanidis, Matthew A Anderson, B. Kate Dredge, Philip A. Gregory, Anna Tsykin, Corine T. Neilsen, Daniel Thomson, Andrew G. Bert, Joanne M. Leerberg, Alpha S. Yap, Kirk B. Jensen, Yeesim Khew‐Goodall, Gregory J. Goodall	2014	115
6	On Measuring miRNAs after Transient Transfection of Mimics or Antisense Inhibitors PLoS ONE ·Daniel Thomson, Cameron P. Bracken, Jan M. Szubert, Gregory J. Goodall	2013	99
7	Global analysis of the mammalian RNA degradome reveals widespread miRNA-dependent and miRNA-independent endonucleolytic cleavage Nucleic Acids Research ·Cameron P. Bracken, Jan M. Szubert, Tim R. Mercer, Marcel E. Dinger, Daniel Thomson, John S. Mattick, Michael Michael, Gregory J. Goodall	2011	69
8	RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses Leukemia ·Shady Adnan Awad, Olli Dufva, Aleksandr Ianevski, Bishwa Ghimire, Jan Koski, Pilvi Maliniemi, Daniel Thomson, Andreas Schreiber, Caroline A. Heckman, Perttu Koskenvesa, Matti Korhonen, Kimmo Porkka, Susan Branford, Tero Aittokallio, Matti Kankainen, Satu Mustjoki	2020	35
9	Assessing the gene regulatory properties of Argonaute-bound small RNAs of diverse genomic origin Nucleic Acids Research ·Daniel Thomson, Katherine A. Pillman, Matthew L. Anderson, David Lawrence, John Toubia, Gregory J. Goodall, Cameron P. Bracken	2014	34
10	Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia Leukemia ·Daniel Thomson, Nur Hezrin Shahrin, Paul Wang, Carol Wadham, Naranie Shanmuganathan, Hamish S. Scott, Marcel E. Dinger, Timothy P. Hughes, Andreas Schreiber, Susan Branford	2020	24
11	Cisplatin‐based therapy: a neurological and neuropsychological review Psycho-Oncology ·Lindsey Troy, Ken McFarland, S. Littman‐Power, Brian Kelly, Euan Walpole, David Wyld, Daniel Thomson	2000	11
12	RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid Leukemia Journal of Molecular Diagnostics ·Naranie Shanmuganathan, Carol Wadham, Daniel Thomson, Nur Hezrin Shahrin, Chloe Vignaud, Vanessa Obourn, Shalini Chaturvedi, Feng Yang, Jinghua Feng, Verity A Saunders, Chung Hoow Kok, David T Yeung, Rob King, Rosalie Kenyon, Ming Lin, Paul Wang, Hamish S. Scott, Timothy P. Hughes, Andreas Schreiber, Susan Branford	2022	5
13	Genetic Risk Assessment of Degenerative Eye Disease (GRADE): study protocol of a prospective assessment of polygenic risk scores to predict diagnosis of glaucoma and age-related macular degeneration BMC Ophthalmology ·Georgina L. Hollitt, Ayub Qassim, Daniel Thomson, Joshua M. Schmidt, Thi Nguyen, John Landers, Stuart MacGregor, Owen M. Siggs, Emmanuelle Souzeau, Jamie E. Craig	2023	3
14	Mutated Cancer-Related Genes Detected at Diagnosis of CML and a Novel Class of Variant Associated with the Philadelphia Translocation Are Both Independent Predictors of Inferior Outcomes Blood ·Naranie Shanmuganathan, Carol Wadham, Nur Hezrin Shahrin, Daniel Thomson, Jinghua Feng, Verity A Saunders, Ming Lin, Rosalie Kenyon, Rob King, Paul Wang, David M. Ross, David T Yeung, Andreas Schreiber, Timothy P. Hughes, Susan Branford	2020	3
15	DNA-PK inhibition enhances gene editing efficiency in HSPCs for CRISPR-based treatment of X-linked hyper IgM syndrome Molecular Therapy — Methods & Clinical Development ·Cole M. Pugliano, Mason P. Berger, Roslyn M. Ray, Kai Sapkos, Betty Wu, Aidan Laird, Yidian Ye, Daniel Thomson, M. Quinn DeGottardi, Iram Khan, Kristina J. Tatiossian, Brodie A. Miles, Florian Aeschimann, Jérôme Pasquier, Mihee M. Kim, David J. Rawlings	2024	1
16	High Recombination Activating Gene (RAG) Expression and RAG Mediated Recombination Is Associated with Oncogenic Rearrangement Observed with Tyrosine Kinase Inhibitor Resistant CML Blood ·Daniel Thomson, Nur Hezrin Shahrin, Paul Wang, Carol Wadham, Timothy P. Hughes, Andreas Schreiber, Susan Branford	2018	1
17	RNA Splicing Defects in Cancer-Linked Genes Indicate Mutation or Focal Gene Deletion and Are Associated with TKI Resistance in CML Blood ·Naranie Shanmuganathan, Daniel Thomson, Carol Wadham, Verity A Saunders, Nur Hezrin Shahrin, David T Yeung, Hamish S. Scott, Timothy P. Hughes, Andreas Schreiber, Susan Branford	2019	1

About Daniel Thomson

Daniel Thomson is a scholar working on Cancer Research, Hematology, Genetics, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 17 papers that have together received 3.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), RNA Research and Splicing (5 papers), Acute Lymphoblastic Leukemia research (4 papers), RNA modifications and cancer (3 papers), RNA Interference and Gene Delivery (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (2.4k citations), Molecular Biology (2.6k citations), Endocrinology (83 citations), Genetics (77 citations) and Immunology (130 citations). Daniel Thomson has collaborated with scholars based in Australia, Switzerland and United States. Frequent co-authors include Marcel E. Dinger, Gregory J. Goodall, Cameron P. Bracken, Nenad Bartoniček, Jesper L.V. Mååg, Michael B. Clark, Bethany Signal, Brian Gloss, Jan M. Szubert and David Lawrence. Their work appears in journals such as Nucleic Acids Research, Blood, Leukemia, The EMBO Journal and Psycho-Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact